H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests;

Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests;

Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests;

H.R. 791 / S. 236, the Tracking COVID-19 Variants Act, provisions relating to funding COVID-19 surveillance and transmission studies using next generation sequencing;

H.R. 1319, Pub. L. 117-2, the American Rescue Plan Act of 2021, provisions relating to funding for genomic sequencing for SARS-CoV-2 variants and diagnostic testing for COVID-19;

H.R. 1946, the Medicare Multi-Cancer Detection Screening Coverage Act, provisions relating to Medicare coverage of multi-cancer screening tests;

H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements;

H.R. 1848, the LIFT America Act, provisions relating to funding of public health infrastructure and public health reporting;

S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests;

Federal policy relating to coverage of genetic counselor services in a draft of the Rare Cancer Awareness, Research and Treatment Act;

Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93;

Federal policy relating to drug development, including potential legislation known as Cures 2.0; and

Federal policy relating to CDC funding for harmonizing lab results in the Fiscal Year 2022 Labor-HHS appropriations bill. DOT Implementation of statutes 49 U.S.C. 41310(A), 49 U.S.C. 44902(B), 49 U.S.C. 41501, and 49 U.S.C. 41704, relating to cargo transport.
HCR - Health Issues TRA - Transportation
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
DONALD HORTON KATHERINE PREGEL DONALD HORTON KATHERINE PREGEL